Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Entheon Biomedical Corp Com C.ENBI

Alternate Symbol(s):  ENTBF

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.


Stock Price Chart (CSE:ENBI)

Fundamentals Snapshot (CSE:ENBI)

Opinion & Analysis (CSE:ENBI)

No current opinion is available.

Bullboard Posts (CSE:ENBI)

Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1...
Betteryear2 - February 27, 2022

Excellent YT analysis on Entheon Biomed

https://youtu.be/6MmeuwtsCqo
BryceCanada - November 8, 2021

Progress

Patient recruitment in progress, steady as she goes! The benifits and personal statements of success in the news.
jerryfurberules - October 29, 2021

Corporate Update on Studies and Clinical Trials

News Release (27-10-21): Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials. Read here: https://finance.yahoo...
Viralstocks1 - October 27, 2021

Long at 80 cts

Any hope left..What is their cash position..will they last another year til the market hopefully turns around.
Hopeful123 - October 25, 2021

RE:Have a great feeling..

$30,000 @ $0.93. Ouch! I hope you're licking your wounds. How low will this drop? I have an order in at $0.20. I think I will get it...
Tslayer - October 21, 2021